MedPath

DEXMEDETOMIDINE

These highlights do not include all the information needed to use DEXMEDETOMIDINE INJECTION safely and effectively. See full prescribing information for DEXMEDETOMIDINE INJECTION. DEXMEDETOMIDINE injection, for intravenous use Initial U.S. Approval: 1999

Approved
Approval ID

aa450b4b-4969-465d-b7f2-8da380bbdbed

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 18, 2020

Manufacturers
FDA

Accord Healthcare Inc.

DUNS: 604222237

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DEXMEDETOMIDINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16729-432
Application NumberANDA204023
Product Classification
M
Marketing Category
C73584
G
Generic Name
DEXMEDETOMIDINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 18, 2020
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXMEDETOMIDINE HYDROCHLORIDEActive
Quantity: 100 ug in 1 mL
Code: 1018WH7F9I
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXMEDETOMIDINE - FDA Drug Approval Details